PD-L1 Status in Gastric Cancers, Association with the Transcriptional, Growth Factors, AKT/mTOR Components Change, and Autophagy Initiation

Introduction: The programmed death receptor ligand 1 (PD-L1) immunohistochemistry (IHC) assay is a widely used selection method for pembrolizumab treatment in gastric cancer (GC) patients. PD-L1 is the main regulator of immunity in oncogenesis. Material and methods: The study included 38 patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Spirina, Liudmila, Avgustinovich, Alexandra, Afanas’ev, Sergei, Volkov, Maxim, Dobrodeev, Alexey, Cheremisina, Olga, Kostromitsky, Dmitry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539424/
https://www.ncbi.nlm.nih.gov/pubmed/34681840
http://dx.doi.org/10.3390/ijms222011176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539424/
https://www.ncbi.nlm.nih.gov/pubmed/34681840
http://dx.doi.org/10.3390/ijms222011176

Ejemplares similares